Extracorporeal Membrane Oxygenation Market Forecast to 2028

Extracorporeal Membrane Oxygenation Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality (Venoarterial extracorporeal membrane oxygenation, Venovenous extracorporeal membrane oxygenation, and Arteriovenous extracorporeal membrane oxygenation), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)

Report Code : TIPHE100001219 | Region : Global | Industry : Medical Device | Published Date : 30/Nov/2022

The extracorporeal membrane oxygenation market is projected to reach US$ 677.64 million by 2028 from US$ 546.73 million in 2021; it is estimated to grow at a CAGR of 3.1% during 2022–2028.

The report highlights the key factors driving the market and prominent players with their developments. The growth of the extracorporeal membrane oxygenation market is primarily attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hinder the growth of the market.

Rising Prevalence of Cardiovascular Diseases and Respiratory Failures Drives extracorporeal membrane oxygenation Market Growth

Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a heart–lungs bypass machine. extracorporeal membrane oxygenation equipment is used in the treatment of cardiovascular diseases and respiratory failures. Millions of deaths due to cardiovascular diseases (CVDs) are recorded every year across the world. CVDs majorly cause mortality and morbidity in Europe, accounting for 45% of deaths in the region and 37% in the European Union (EU). As per the study ‘Global Burden of Disease Study 2019,’ CVDs were among the leading causes of death in Asia in 2019, causing 10.8 million fatalities (35% of the total fatalities). According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, an estimated 119.1 million patients died of CVDs across the world in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. High instances of CVDs are observed in North America. As per the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, ~697,000 people succumbed to heart disease in the US. According to the American Heart Association, over 130 million people in the US (45.1% of total population) are likely to get affected by some form of cardiovascular disease by 2035. Further, according to the National Library of Medicine, in 2022, about 400,000 coronary artery bypass grafting (CABG) surgeries are performed every year.

Chronic obstructive pulmonary disease (COPD) causes obstruction in the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the world. According to World Health Organization (WHO), COPD was the third leading cause of death, which caused 3.23 million deaths across the globe in 2019. About 90% of COPD deaths occur in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, COPD was the sixth leading cause of death in the US. Therefore, the growing prevalence of cardiovascular diseases and respiratory failures drives the growth of the extracorporeal membrane oxygenation market.

The global extracorporeal membrane oxygenation market, based on modality, is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. The venoarterial extracorporeal membrane oxygenation segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 3.1% in the market during the forecast period. Venoarterial (VA) extracorporeal membrane oxygenation supports the patient's heart and lungs by pushing the blood through the circuit without getting through the patient's heart. This type of extracorporeal membrane oxygenation takes blood out of a large vein and back it into a large artery, allowing oxygen-rich blood to circulate through the body even if the heart is too weak to pump. Veno-arterial extracorporeal membrane oxygenation (VA-extracorporeal membrane oxygenation) has been widely applied over the last decade. It is an effective and valuable therapeutic option in refractory cardiogenic shock of various etiologies. It showed promising results in the specific setting of in-hospital cardiac arrest, and survival rates with good neurological outcomes are reported between 20% and 40%.

Based on application, the global extracorporeal membrane oxygenation market is bifurcated into respiratory and cardiology. The respiratory segment held a larger share of the market in 2021 as extracorporeal membrane oxygenation is used for patients recovering from lung failure. Acute respiratory distress syndrome (ARDS), Blockage in a pulmonary artery in the lungs (pulmonary embolism), and COVID-19 are a few lung diseases where extracorporeal membrane oxygenation is used. extracorporeal membrane oxygenation can support patients body in total absence of lung function. However, the cardiology segment is anticipated to register a CAGR of 3. 6% in the market during the forecast period. extracorporeal membrane oxygenation is also used to support people affected by heart disease that cannot be cured while they wait for an organ transplant. It is used in the treatment of heart attack (acute myocardial infarction), heart muscle disease (decompensated cardiomyopathy), and heart failure. As per the WHO, in 2019, due to CVDs ~17.9 million deaths were recorded accounting for 32% of all global deaths. Increasing prevalence of cardiovascular diseases is likely to increase the demand for extracorporeal membrane oxygenation machines in the coming years.

Food and Drug Administration, Ministry of Statistics and Program Implementation, National Institute of Statistics and Geography, and National Medical Products Administration are a few of the major primary and secondary sources referred to while preparing the report on the extracorporeal membrane oxygenation market.

Increasing Survival Rates with extracorporeal membrane oxygenation to Offer Lucrative Opportunities for Global extracorporeal membrane oxygenation Market during 2022–2028

According to our new research study on "Extracorporeal Membrane Oxygenation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, Application, and Age Group," the market was valued at US$ 546.73 million in 2021 and is projected to reach US$ 677.64 million by 2028. It is estimated to grow at a CAGR of 3.1% from 2022 to 2028. The rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures are driving the market growth. However, the high cost of vaccine development hampers the market growth.

Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a life support machine used to treat cardiovascular disease and respiratory failure cases. It supports people suffering from heart disease and waiting for an organ transplant. Blockage in a pulmonary artery in the lungs (pulmonary embolism), acute respiratory distress syndrome (ARDS), and COVID-19 are lung diseases where extracorporeal membrane oxygenation is used.

The employment of extracorporeal membrane oxygenation for treating respiratory failure has been increasing in recent years, as treatments with extracorporeal membrane oxygenation are showing promising survival rates. According to BioMed Central, in 2021, the survival rate of respiratory failure patients suffering from COVID-19 was 60% with the treatment using veno-venous extracorporeal membrane oxygenation (V-V extracorporeal membrane oxygenation). Further, extracorporeal membrane oxygenation is recommended to treat patients affected by acute respiratory distress syndrome (ADRS), primary graft dysfunction post lung transplant, and trauma to the lungs as it increases the survival rate of patients. Furthermore, extracorporeal membrane oxygenation increases the survival rate of patients affected by post-cardiac arrest regimens. A radical shift in adopting westernized lifestyles leads to various cardiac disorders. Thus, key players invest significantly in R&D, which results in improved treatment outcomes with extracorporeal membrane oxygenation with an increased survival rate. Thus, the rising survival rate using extracorporeal membrane oxygenation in various treatments is expected to offer lucrative opportunities for the extracorporeal membrane oxygenation market during the forecast period.

By region, the global extracorporeal membrane oxygenation market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the US is the largest market. The market in Asia Pacific is expected to grow at the fastest rate during the forecast period. Increasing investments in healthcare infrastructure, strong government support for the healthcare sector, and a large patient population suffering from heart and lung diseases are among the major factors driving the growth of the extracorporeal membrane oxygenation market. According to an article by the National Center for Biotechnology Information (NCBI) on "Cardiovascular Health and Diseases in China," ~ 47% and 44% of all deaths in rural and urban areas, respectively, were recorded due to cardiovascular disease (CVD) in 2019. India, China, Japan, and other countries in Asia Pacific have a significantly growing healthcare sector. Therefore, the region is expected to hold vast potential for the extracorporeal membrane oxygenation market during the forecast period. Furthermore, the penetration of international market players in the China is boosting the growth of the market. In July 2021, Xenios AG, a Fresenius Medical Care company, received approval from the National Medical Products Administration (NMPA) in China for the Xenios console and patient kits for extracorporeal membrane oxygenation therapy.

Terumo Group, Medtronic Plc, MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and Abiomed Inc are among the leading companies operating in the extracorporeal membrane oxygenation market.

The report segments the extracorporeal membrane oxygenation market as follows:

Based on modality, the extracorporeal membrane oxygenation market is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. Based on application, the market is bifurcated into cardiology and respiratory. In terms of age group, the market is segmented into neonates, pediatrics, and adults. By geography, the global extracorporeal membrane oxygenation market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Extracorporeal Membrane Oxygenation Market – By Modality

1.3.2 Global Extracorporeal Membrane Oxygenation Market – By Application

1.3.3 Global Extracorporeal Membrane Oxygenation Market – By Age Group

1.3.4 Global Extracorporeal Membrane Oxygenation Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Extracorporeal Membrane Oxygenation Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Experts Opinion

5. Extracorporeal Membrane Oxygenation Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures

5.1.2 Growing Adoption of Extracorporeal Membrane Oxygenation in Lung Transplantation Procedures

5.2 Market Restraints

5.2.1 Complications Associated with Extracorporeal Membrane Oxygenation

5.3 Market Opportunities

5.3.1 Increasing Survival Rates with Extracorporeal Membrane Oxygenation

5.4 Future Trends

5.4.1 Surging Product Developments and Approvals

5.5 Impact Analysis

6. Extracorporeal Membrane Oxygenation Market – Global Analysis

6.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis

6.1.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis

6.2 Market Positioning Analysis of Key Players in Extracorporeal Membrane Oxygenation Market

7. Extracorporeal Membrane Oxygenation Market Analysis and Forecast To 2028 – By Modality

7.1 Overview

7.2 Global Extracorporeal Membrane Oxygenation Market Share by Modality 2021 & 2028 (%)

7.3 Venoarterial Extracorporeal Membrane Oxygenation

7.3.1 Overview

7.3.2 Venoarterial Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

7.4 Venovenous Extracorporeal Membrane Oxygenation

7.4.1 Overview

7.4.2 Venovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

7.5 Arteriovenous Extracorporeal Membrane Oxygenation

7.5.1 Overview

7.5.2 Arteriovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

8. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 – By Application

8.1 Overview

8.2 Global Extracorporeal Membrane Oxygenation Market, By Application 2021 & 2028 (%)

8.3 Cardiology

8.3.1 Overview

8.3.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Respiratory

8.4.1 Overview

8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)

9. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 – By Age Group

9.1 Overview

9.2 Global Extracorporeal Membrane Oxygenation Market, By Age Group 2021 & 2028 (%)

9.3 Neonates

9.3.1 Overview

9.3.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Pediatrics

9.4.1 Overview

9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)

9.5 Adults

9.5.1 Overview

9.5.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)

10. Extracorporeal Membrane Oxygenation Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Extracorporeal Membrane Oxygenation Market

10.1.1 Overview

10.1.2 North America: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.1.4 North America: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.1.5 North America: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.1.6 North America: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 US: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.1.6.1.4 US: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.1.6.1.5 US: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.1.6.2 Canada: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3 Canada: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.1.6.2.4 Canada: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.1.6.2.5 Canada: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.1.6.3 Mexico: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3 Mexico: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.1.6.3.4 Mexico: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.1.6.3.5 Mexico: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.2 Europe: Extracorporeal Membrane Oxygenation Market

10.2.1 Overview

10.2.2 Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019–2028 (US$ Million)

10.2.4 Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.2.5 Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.2.6 Europe: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Overview

10.2.6.1.2 Germany: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3 Germany: Extracorporeal Membrane Oxygenation Market, By Modality, 2019–2028 (US$ Million)

10.2.6.1.4 Germany: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.2.6.1.5 Germany: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.2.6.2 UK: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 Overview

10.2.6.2.2 UK: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3 UK: Extracorporeal Membrane Oxygenation Market, By Modality, 2019–2028 (US$ Million)

10.2.6.2.4 UK: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.2.6.2.5 UK: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.2.6.3 France: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 Overview

10.2.6.3.2 France: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3 France: Extracorporeal Membrane Oxygenation Market, By Modality, 2019–2028 (US$ Million)

10.2.6.3.4 France: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.2.6.3.5 France: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.2.6.4 Italy: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3 Italy: Extracorporeal Membrane Oxygenation Market, By Modality, 2019–2028 (US$ Million)

10.2.6.4.4 Italy: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.2.6.4.5 Italy: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)

10.2.6.5 Spain: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3 Spain: Extracorporeal Membrane Oxygenation Market, By Modality, 2019–2028 (US$ Million)

10.2.6.5.4 Spain: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.2.6.5.5 Spain: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.2.6.6 Rest of Europe: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3 Rest of Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019–2028 (US$ Million)

10.2.6.6.4 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.2.6.6.5 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market

10.3.1 Overview

10.3.2 Asia Pacific: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.3.4 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.3.5 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.3.6 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 China: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.3 China: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.3.6.1.4 China: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.3.6.1.5 China: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.3.6.2 Japan: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 Japan: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.3 Japan: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.3.6.2.4 Japan: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.3.6.2.5 Japan: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.3.6.3 India: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.3 India: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.3.6.3.4 India: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.3.6.3.5 India: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.3.6.4 South Korea: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 South Korea: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.3 South Korea: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.3.6.4.4 South Korea: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.3.6.4.5 South Korea: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.3.6.5 Australia: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 Australia: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.3 Australia: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.3.6.5.4 Australia: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.3.6.5.5 Australia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.3.6.6 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020–2028 (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020–2028 (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020–2028 (US$ Million)

10.4 South & Central America Extracorporeal Membrane Oxygenation Market

10.4.1 Overview

10.4.2 South & Central America: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

10.4.3 South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)

10.4.4 South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)

10.4.5 South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)

10.4.6 South & Central America: Extracorporeal Membrane Oxygenation, by Country, 2021 & 2028 (%)

10.4.6.1 Brazil: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.1 Brazil: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.2 Brazil: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)

10.4.6.1.3 Brazil: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)

10.4.6.1.4 Brazil: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)

10.4.6.2 Argentina: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.1 Argentina: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.2 Argentina: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)

10.4.6.2.3 Argentina: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)

10.4.6.2.4 Argentina: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)

10.4.6.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.1 Rest of South & Central America: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.2 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)

10.4.6.3.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)

10.4.6.3.4 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)

10.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market

10.5.1 Middle East & Africa: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

10.5.2 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019–2028 (US$ Million)

10.5.3 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.5.4 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.5.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Country, 2021& 2028 (%)

10.5.5.1 South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)

10.5.5.1.1 Overview

10.5.5.1.2 South Africa: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

10.5.5.1.3 South Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019–2028 (US$ Million)

10.5.5.1.4 South Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.5.5.1.5 South Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.5.5.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

10.5.5.2.1 Overview

10.5.5.2.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

10.5.5.2.3 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Modality, 2019–2028 (US$ Million)

10.5.5.2.4 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.5.5.2.5 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.5.5.3 UAE: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

10.5.5.3.1 Overview

10.5.5.3.2 UAE: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

10.5.5.3.3 UAE: Extracorporeal Membrane Oxygenation Market, by Modality, 2019–2028 (US$ Million)

10.5.5.3.4 UAE: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.5.5.3.5 UAE: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

10.5.5.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)

10.5.5.4.1 Overview

10.5.5.4.2 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

10.5.5.4.3 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019–2028 (US$ Million)

10.5.5.4.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019–2028 (US$ Million)

10.5.5.4.5 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019–2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Extracorporeal Membrane Oxygenation Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 South & Central America: Impact Assessment of COVID-19 Pandemic

11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Extracorporeal Membrane Oxygenation Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Extracorporeal Membrane Oxygenation Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Terumo Group

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Medtronic Plc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MicroPort Scientific Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 LivaNova Plc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Nipro Medical Corporation

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Eurosets S.R.L.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Getinge AB

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Braile Biomedica

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Fresenius Medical Care AG & Co KGaA

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 ABIOMED Inc

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 6. US Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 10. Mexico Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 13. Europe: Extracorporeal Membrane Oxygenation Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 14. Europe: Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 15. Europe Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 16. Germany: Extracorporeal Membrane Oxygenation Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 17. Germany: Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 18. Germany: Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 19. UK: Extracorporeal Membrane Oxygenation Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 20. UK: Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 21. UK: Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 22. France: Extracorporeal Membrane Oxygenation Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 23. France: Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24. France: Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy: Extracorporeal Membrane Oxygenation Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy: Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 27. Italy: Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 28. Spain: Extracorporeal Membrane Oxygenation Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain: Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: Extracorporeal Membrane Oxygenation Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 34. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 35. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 36. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 37. China Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 38. China Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 39. China Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 40. Japan Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 41. Japan Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 42. Japan Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 43. India Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 44. India Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 45. India Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 46. South Korea Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 47. South Korea Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 48. South Korea Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 49. Australia Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 50. Australia Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 51. Australia Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 55. South & Central America Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 56. South & Central America Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 57. South & Central America Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

Table 58. Brazil Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 59. Brazil Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 60. Brazil Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

Table 61. Argentina Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 62. Argentina Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 63. Argentina Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

Table 64. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 65. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 66. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

Table 67. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 68. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 69. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 70. South Africa Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 71. South Africa Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 72. South Africa Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 73. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 74. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 75. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 76. UAE Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 77. UAE Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 78. UAE Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 79. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 80. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 81. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 82. Recent Inorganic Growth Strategies in the Extracorporeal Membrane Oxygenation Market

Table 83. Recent Organic Growth Strategies in the Extracorporeal Membrane Oxygenation Market

Table 84. Glossary of Terms

LIST OF TABLES.

Figure 1. Extracorporeal Membrane Oxygenation Market Segmentation

Figure 2. Extracorporeal Membrane Oxygenation Market, By Region

Figure 3. Global Extracorporeal Membrane Oxygenation Market Overview

Figure 4. Venoarterial Extracorporeal Membrane Oxygenation Held Largest Share for Modality Segment in Extracorporeal Membrane Oxygenation Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Extracorporeal Membrane Oxygenation Market, by Geography (US$ Million)

Figure 7. Global Extracorporeal Membrane Oxygenation Market - Leading Country Markets (US$ Million)

Figure 8. Global Extracorporeal Membrane Oxygenation Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East & Africa: PEST Analysis

Figure 13. South & Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Impact Analysis

Figure 16. Global Extracorporeal Membrane Oxygenation Market – Revenue Forecast and Analysis – 2020- 2028

Figure 17. Global Extracorporeal Membrane Oxygenation Market – Revenue Forecast & Analysis – 2021 - 2028

Figure 18. Market Positioning Analysis of Key Players in Global Extracorporeal Membrane Oxygenation Market

Figure 19. Global Extracorporeal Membrane Oxygenation Market Share by Modality 2021 & 2028 (%)

Figure 20. Venoarterial Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)

Figure 21. Venovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)

Figure 22. Arteriovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)

Figure 23. Global Extracorporeal Membrane Oxygenation Market, by Application 2021 & 2028 (%)

Figure 24. Cardiology Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Respiratory Market Revenue and Forecasts To 2028 (US$ MN)

Figure 26. Global Extracorporeal Membrane Oxygenation Market, by Age Group 2021 & 2028 (%)

Figure 27. Neonates Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Pediatrics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Adults Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. North America: Extracorporeal Membrane Oxygenation Market, by Key Country – Revenue (2021) (US$ Million)

Figure 31. North America Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

Figure 32. North America: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)

Figure 33. US: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Canada: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Mexico: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Europe: Extracorporeal Membrane Oxygenation Market, by Key Country – Revenue (2021) (US$ Million)

Figure 37. Europe Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

Figure 38. Europe: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)

Figure 39. Germany: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. UK: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. France: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Italy: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Spain: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Rest of Europe: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Key Country – Revenue (2021) (US$ Million)

Figure 46. Asia Pacific Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

Figure 47. Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)

Figure 48. China: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. Japan: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. India: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. South Korea: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. Australia: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. South & Central America: Extracorporeal Membrane Oxygenation Market, by Key Country – Revenue (2021) (US$ Million)

Figure 55. South & Central America Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

Figure 56. South & Central America: Extracorporeal Membrane Oxygenation, by Country, 2021 & 2028 (%)

Figure 57. Brazil: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

Figure 58. Argentina: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

Figure 59. Rest of South & Central America: Extracorporeal Membrane Oxygenation – Revenue and Forecast to 2028 (US$ Million)

Figure 60. Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Key Country – Revenue (2021) (US$ Million)

Figure 61. Middle East & Africa Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

Figure 62. Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Country, 2021& 2028 (%)

Figure 63. South Africa: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 64. Saudi Arabia: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 65. UAE: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 66. Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 67. Impact of COVID-19 Pandemic on North American Countries Markets

Figure 68. Impact of COVID-19 Pandemic in European Country Markets

Figure 69. Impact of COVID-19 Pandemic on Asia Pacific Country Markets

Figure 70. Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 72. Growth Strategies in the Extracorporeal Membrane Oxygenation Market

The List of Companies - Extracorporeal Membrane Oxygenation Market

• Terumo Group

• Medtronic Plc

• MicroPort Scientific Corporation

• LivaNova Plc

• Nipro Medical Corporation

• Eurosets S.R.L.

• Getinge AB

• Braile Biomedica

• Fresenius Medical Care AG & Co KGaA

• ABIOMED Inc

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the extracorporeal membrane oxygenation market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global extracorporeal membrane oxygenation market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TOP